Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reinders

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
Transplantation|January 26, 2013
Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantationDorottya K de Vries, Pieter van der Pol, Gerritje E van Anken, et al.
Plos One|January 30, 2025
Long-term Double-J stenting is superior to short-term Single-J stenting in kidney transplantationChristiaan A J Oudmaijer, Kelly Muller, Erika van Straalen, et al.
PEC Innovation|May 22, 2023
Didactical characteristics of Dutch websites about kidney transplantation targeted for kidney patients and living donors: An exploratory studyCharlotte W van Klaveren, Peter G M de Jong, Renée A Hendriks, et al.
Frontiers in Genetics|October 14, 2024
Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?Suzanne Bezstarosti, Pauline Erpicum, Gianni Maggipinto, et al.
Stem Cells and Development|September 22, 2021
Identification of Predictive Markers for the Generation of Well-Differentiated Human Induced Pluripotent Stem Cell-Derived Kidney OrganoidsZhaoyu Du, Anusha S Shankar, Thierry P P van den Bosch, et al.
Clinical Pharmacology and Therapeutics|May 15, 2025
Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney TransplantationLukas K van Vugt, Tom C Zwart, Suzanne Bezstarosti, et al.
Cytotherapy|August 18, 2011
Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel diseaseMarjolijn Duijvestein, Ilse Molendijk, Helene Roelofs, et al.
Transplantation Direct|October 17, 2022
Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant RecipientsSophie C Frölke, Pim Bouwmans, A Lianne Messchendorp, et al.
Stem Cells Translational Medicine|February 14, 2017
Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative MedicineDaniëlle G Leuning, Marlies E J Reinders, Joan Li, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 29, 2023
A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant RejectionLukas K van Vugt, Marieke van der Zwan, Marian C Clahsen-van Groningen, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Transplantation|January 26, 2013
Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantationDorottya K de Vries, Pieter van der Pol, Gerritje E van Anken, et al.
Plos One|January 30, 2025
Long-term Double-J stenting is superior to short-term Single-J stenting in kidney transplantationChristiaan A J Oudmaijer, Kelly Muller, Erika van Straalen, et al.
PEC Innovation|May 22, 2023
Didactical characteristics of Dutch websites about kidney transplantation targeted for kidney patients and living donors: An exploratory studyCharlotte W van Klaveren, Peter G M de Jong, Renée A Hendriks, et al.
Frontiers in Genetics|October 14, 2024
Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?Suzanne Bezstarosti, Pauline Erpicum, Gianni Maggipinto, et al.
Stem Cells and Development|September 22, 2021
Identification of Predictive Markers for the Generation of Well-Differentiated Human Induced Pluripotent Stem Cell-Derived Kidney OrganoidsZhaoyu Du, Anusha S Shankar, Thierry P P van den Bosch, et al.
Clinical Pharmacology and Therapeutics|May 15, 2025
Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney TransplantationLukas K van Vugt, Tom C Zwart, Suzanne Bezstarosti, et al.
Cytotherapy|August 18, 2011
Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel diseaseMarjolijn Duijvestein, Ilse Molendijk, Helene Roelofs, et al.
Transplantation Direct|October 17, 2022
Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant RecipientsSophie C Frölke, Pim Bouwmans, A Lianne Messchendorp, et al.
Stem Cells Translational Medicine|February 14, 2017
Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative MedicineDaniëlle G Leuning, Marlies E J Reinders, Joan Li, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 29, 2023
A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant RejectionLukas K van Vugt, Marieke van der Zwan, Marian C Clahsen-van Groningen, et al.
Pageof 22